Tetrahydrouridine
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Tetrahydrouridine, covering 2014-11-25 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS) [Phase 1]